Navigation Links
Genzyme Announces Successful Completion of Study Investigating,Sevelamer Carbonate in Patients With Chronic Kidney Disease

arly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.

Genzyme(R) and Renagel(R) are registered trademarks and Renvela(TM) is a trademark of Genzyme Corporation. All rights reserved.

Genzyme's press releases and other company information are available at www.genzyme.com and by calling Genzyme's investor information line at 1-800- 905-4369 within the United States or 1-703-797-1866 outside the United States.

     Media Contact:        Investor Contact:

     Bo Piela              Sally Curley

     (617) 768-6579        (617) 768-6140

CONTACT: Media, Bo Piela, +1-617-768-6579, or Investors, Sally Curley,+1-617-768-6140, both of Genzyme Corp.

Web site: http://www.genzyme.com/http://www.renagel.com/

Company News On-Call: http://www.prnewswire.com/comp/104284.html /

Ticker Symbol: (NASDAQ-NMS:GENZ)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
2. Genzyme Announces Results of Clinical Trial of Hylastan
3. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
4. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
5. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:1/15/2014)... Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... tender offer by its indirect wholly-owned subsidiary, Sapphire Subsidiary ... common stock of Solta Medical, Inc. (NASDAQ: ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014 HeartWare ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that it expects revenues for the fourth ... expected full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... 2014 /PRNewswire-iReach/ -- Acumed,s new SLIC Screw System - ... instrumentation to place and insert the screw accurately - ... (e.g. ligament) repair or reconstruction as it holds the ... (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) The SLIC ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3
... April 4, 2011 Milestone Scientific Inc. (OTCQB: MLSS), the ... results for the year ended December 31, 2010. ... with 12-Month Ended December 31, 2009: Total ... Sales in the U.S. decreased 16% to $4.53 million from ...
... significant need to improve efficiency and provide cost-savings throughout ... it is initially targeting the $2 billion orthopedic trauma ... implants and instruments.   "Hospitals are increasingly ... medical care. Emerge Medical was created to meet this ...
Cached Medicine Technology:Milestone Scientific Announces 2010 Year End Results 2Milestone Scientific Announces 2010 Year End Results 3Milestone Scientific Announces 2010 Year End Results 4Milestone Scientific Announces 2010 Year End Results 5Milestone Scientific Announces 2010 Year End Results 6Emerge Medical Targets $92 Billion Medical Device Market With Lower-Cost Generic Implants and Instruments 2
(Date:4/18/2014)... Simon Fraser University psychologists have made a brain-related ... of attention-deficit disorders. , This discovery opens up ... hinder or suppress a specific brain activity that ... distraction. , The Journal of Neuroscience ... by John McDonald, an associate professor of psychology ...
(Date:4/17/2014)... of chronic inflammation in benign prostate tissue was ... this association was found even in those with ... study published in Cancer Epidemiology, Biomarkers & ... for Cancer Research. , An analysis of prostate ... placebo arm of the Prostate Cancer Prevention Trial ...
(Date:4/17/2014)... of the most popular vaccine brands for children may ... be overlooking some cost factors when choosing vaccines, driving ... option, according to a new study by University of ... can be driven by numerous factors," says Sheldon H. ... of computer science and of mathematics at the U. ...
(Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
(Date:4/17/2014)... 2014U.S. military personnel who served in Iraq and ... brain injury (TBI) were compared to military personnel ... reasons. Differences in measures of overall disability, cognitive ... injury are reported in an article in ... Mary Ann Liebert, Inc., publishers. The article is ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2
... (HealthDay News) -- Smoky, inefficient indoor cooking and heating stoves ... to 2 million deaths a year, according to health experts. ... billion people, or nearly half the world,s population, the U.S. ... published in the current issue of the journal Science ...
... HealthDay Reporter , THURSDAY, Oct. 13 (HealthDay News) -- ... toting sports gear, water bottles and lawn chairs converge ... Pretty much everyone agrees that the nation,s kids ... that organized sports can help achieve that. Yet, some ...
... Notre Dame have announced a breakthrough approach to allergy ... reactions without suppressing a sufferer,s entire immunological system. ... designed, a heterobivalent ligand (HBL), which when introduced into ... egg or peanut proteins in their race to attach ...
... are involved in their children,s health and encourage them to ... Northwestern University Feinberg School of Medicine. But these same dads ... and may be uncomfortable handling emergency medical care for their ... these fathers, perceptions of their participation in their children,s health ...
... therapeuticsantibiotics, antivirals and an antitoxinto prevent or treat diseases ... contracts awarded by the National Institute of Allergy and ... Health. Total funding for the four contracts could reach ... The contracts are designed to support essential research and ...
... (HealthDay News) -- Nearly one in four Americans with the ... psoriatic arthritis, according to a new study. This is ... States who have been diagnosed with the disease, a type ... can lead to joint destruction and disability. For the ...
Cached Medicine News:Health News:Globally, 2 Million Deaths a Year Linked to Smoky Stoves 2Health News:Overzealous Parents, Coaches Take the Fun From Kids' Sports 2Health News:Overzealous Parents, Coaches Take the Fun From Kids' Sports 3Health News:Overzealous Parents, Coaches Take the Fun From Kids' Sports 4Health News:Researchers engineer a new way to inhibit allergic reactions without side effects 2Health News:Lower income dads active in their kids' health 2Health News:Lower income dads active in their kids' health 3Health News:NIH funds development of new broad-spectrum therapeutics 2Health News:NIH funds development of new broad-spectrum therapeutics 3Health News:1 in 4 With Psoriasis May Have Undiagnosed Arthritis 2
ENDOlap™ suction and irrigation trumpet valves...
Diamond Reusable Probed work with all ACMI™ instrument inserts. Dual trumpet valves provide smooth, effective fingertip control over suction and irrigation....
... the Prosound ALPHA 10 System offers ... in an intuitive and ergonomically designed ... system for Perinatology/Maternal & Fetal Medicine ... Breast Imaging, and General Imaging departments ...
Corson Suction-Irrigation Probes are designed to provide flexibility and reliability in a disposable probe....
Medicine Products: